市场调查报告书
商品编码
1390848
奈米孔技术市场:2023-2028 年全球产业趋势、份额、规模、成长、机会与预测Nanopore Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年全球奈米孔技术市场规模达2.444亿美元。展望未来, IMARC Group预计到2028年市场规模将达到5.115亿美元,2022-2028年复合年增长率(CAGR)为13.10%。
奈米孔技术是指无需对样本进行聚合酶炼式反应(PCR)扩增和化学标记的单分子脱氧核糖核酸(DNA)的新一代分子定序。它提供相对高的通量和低成本的基因分型、测试的高移动性、即时快速处理样品以及无标记的超长读取。它用作诊断工具,提供快速分析、消除繁琐的扩增和转换步骤、检测极低浓度的目标分子以及筛选生物标记或基因组。如今,由于先进的奈米孔蛋白质和化学物质的引入,奈米孔技术的读取品质已显着提高。
冠状病毒病(COVID-19)的爆发,加上开发潜在治疗方法的迫切需要,是推动全球奈米孔技术需求的关键因素之一。研究人员广泛依赖这些技术来产生资料,从病毒基因组的初步表征到变种的快速识别,这对于对抗疫情的传播至关重要。除此之外,由于吸烟、饮酒、肥胖和慢性发炎的人数不断增加,很大一部分人口中癌症盛行率不断上升,这也促进了市场的成长。奈米孔技术用于肿瘤学领域,透过检测和准确定量 microRNA 来促进癌症诊断和治疗。此外,领先的市场参与者正在推出新一代感测技术,该技术利用嵌入高科技电子产品中的奈米孔来执行精确的分子分析。这项技术在临床诊断、流行病学、食品安全、农业和环境科学等应用领域已被广泛采用。预计此类创新将对市场产生正面影响。
The global nanopore technologies market size reached US$ 244.4 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 511.5 Million by 2028, exhibiting a growth rate (CAGR) of 13.10% during 2022-2028.
Nanopore technology refers to the next-generation molecule sequencing of single-molecule deoxyribonucleic acid (DNA) without the need for polymerase chain reaction (PCR) amplification and chemical labeling of the sample. It offers a relatively high throughput and low-cost genotyping, high mobility for testing, rapid processing of samples in real-time, and label-free, ultralong reads. It is used as a diagnostic tool to provide a fast analysis, eliminate cumbersome amplification and conversion steps, and detect target molecules at very low concentrations and screen panels of biomarkers or genes. Nowadays, the read quality of nanopore technology has improved significantly on account of the introduction of advanced nanopore proteins and chemistries.
The outbreak of the coronavirus disease (COVID-19), in confluence with the urgent need to develop a potential treatment, represents one of the key factors driving the need for nanopore technologies worldwide. Researchers are extensively relying on these technologies to generate data, ranging from initial characterization of the virus genome to the rapid identification of variants, essential to combating the spread of the pandemic. Apart from this, the increasing prevalence of cancer among a significant part of the population due to the rising number of individuals who smoke, drink, and have obesity and chronic inflammation is contributing to the market growth. Nanopore technologies are used in oncology settings for facilitating cancer diagnosis and treatment through the detection and accurate quantification of microRNA. In addition, leading market players are introducing a new generation of sensing technology that uses nanopores embedded in high-tech electronics to perform precise molecular analyses. This technology is gaining widespread adoption in applied settings, such as clinical diagnostics, epidemiology, food safety, agriculture, and environmental science. Such innovations are projected to influence the market positively.
IMARC Group provides an analysis of the key trends in each sub-segment of the global nanopore technologies market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and end user.
Instruments
Portable
Benchtop
Consumables
DNA Sequencing
RNA Sequencing
Others
Hospitals and Clinics
Research Institutes
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Cyclomics BV, Electronic Biosciences Inc., Inanobio Inc., Nabsys Inc., Ontera Inc., Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., Quantapore Inc., Roche Holding AG and Tracxn Technologies Limited.